American International Group’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-15,421
Closed -$16.5K – 3093
2023
Q1
$16.5K Buy
15,421
+307
+2% +$587 ﹤0.01% 2914
2022
Q4
$39.4K Buy
15,114
+111
+0.7% +$485 ﹤0.01% 2809
2022
Q3
$105K Buy
15,003
+212
+1% +$1.66K ﹤0.01% 2526
2022
Q2
$101K Buy
14,791
+873
+6% +$8.91K ﹤0.01% 2591
2022
Q1
$196K Sell
13,918
-981
-7% -$13.1K ﹤0.01% 2251
2021
Q4
$216K Buy
14,899
+6,110
+70% +$86.9K ﹤0.01% 2321
2021
Q3
$124K Buy
8,789
+4,129
+89% +$63.5K ﹤0.01% 2695
2021
Q2
$82K Buy
4,660
+188
+4% +$3.03K ﹤0.01% 2919
2021
Q1
$68K Buy
+4,472
New +$63.7K ﹤0.01% 2890

Other funds holding BVS

American International Group's BVS Position: Q2 2023 in Review

American International Group sold out of Bioventus (BVS) in Q2 2023, closing a stake of 15,421 shares — an estimated $16.5K sold.

American International Group first reported a position in BVS in Q1 2021 and held it in 9 quarters. The position peaked at $216K in Q4 2021. 66 funds tracked by Wall St. Rank hold BVS as of Q2 2023.

  • American International Group reported no remaining Bioventus position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 15,421 Bioventus shares in Q2 2023, an estimated $16.5K.
  • American International Group first reported a position in Bioventus in Q1 2021 and held it in 9 quarters.
  • American International Group's Bioventus position peaked at $216K in Q4 2021.
  • 66 funds tracked by Wall St. Rank held Bioventus as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.